Allen Campbell, JD, MBA — Founder and CEO
Leading light in Sustainability, with a deep understanding of the theory and practice of ESG. Informed by legal, financial and business experience. Authority on Value Chain Sustainability legislation. (See elsewhere in this website.) Effective communicator, skilled negotiator, adept at helping businesses and stakeholders “do ESG” well.
Allen understands that ESG, compliance and risk management are inherently intertwined. He is the creator of the R-ESG Model, which integrates Resilience (both business resilience and personal resilience) with ESG. Allen is also the creator of other proprietary systems for managing risk, compliance, ESG and resilience.
Allen is a graduate of the College of Wooster (AB), Columbia University (JD) and the University of Chicago (MBA) where he studied under three Nobel laureates. He started his professional life as an attorney with the Taft law firm (featured in the Dark Waters environmental justice movie). He was later an investment banker in New York in the corporate finance department of Bear Stearns, a major bracket investment bank that pioneered what became known as “private equity”. Allen then spent a year in Cambridge, Massachusetts as a full-time strategic advisor to the the chief executive of Arthur D. Little Inc., a leading international consulting firm, and the president of its ADL Enterprises unit. Allen then came to Dallas where he directed the corporate finance department of the regional investment banking firm Schneider Bernet & Hickman.
With all that educational and professional background, Allen became an entrepreneur.
He has founded, co-founded, owned or co-owned, many companies, including an investment research business whose quantitative work won many industry awards, and magazine companies that published American Visions, the official magazine of the African American Museums Association, and Marlin, about big game sport fishing. Allen created Murex Corporation, a biotechnology leader in the war against AIDS. Murex invented and commercialized the acclaimed Single Use Diagnostic System for HIV-1 (“SUDS”), which was the first, and for years the only, product approved by the U.S. Food and Drug Administration’s (FDA) for rapid HIV testing. Murex became International Murex Technologies, which became a publicly held company, and was thereafter acquired by Abbott Labs.
